Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms

Mollie M. McDonnell(University of Washington), Michael Emerman(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
bioRxiv (Cold Spring Harbor Laboratory)
April 6, 2021
Cited by 3


Related Papers